Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 4/20 | 0.48 |
| ▸ | PPARD | Q03181 | 4/20 | 0.48 |
| ▸ | PPARA | Q07869 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | FABP4 | P15090 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11166899 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748958 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL15475470 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL11166892 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748235 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748226 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748228 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748950 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL15475400 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL9748955 | 1.00 | HSP90AA1 (0.53) | HSP90AA1FAAHMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9309486-B2 | Cleaning agent composition | AJINOMOTO CO., INC. (JP) | 2016-04-12 | — | — | US | disclosed |
| EP-2703478-B1 | CLEANING AGENT COMPOSITION | AJINOMOTO KK (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-9226884-B2 | Liquid cleansing composition | AJINOMOTO CO., INC. (JP) | 2016-01-05 | — | — | US | disclosed |
| EP-2703478-A1 | CLEANING AGENT COMPOSITION | Ajinomoto Co., Inc. (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20140051772-A1 | CLEANING AGENT COMPOSITION | AJINOMOTO CO., INC. (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20140051651-A1 | LIQUID CLEANSING COMPOSITION | AJINOMOTO CO., INC. (JP) | 2014-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051772-A1 | CLEANING AGENT COMPOSITION | SORT1, ASAH1, ABHD16A | HSP90AA1 3850/4885FAAH 13/4885MEN1 4813/4885 |
| US-20140051651-A1 | LIQUID CLEANSING COMPOSITION | ABHD16A, TREH, ABHD12 | HSP90AA1 4730/4885FAAH 10/4885MEN1 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.